- McKesson has increased its forecast for the full-year adjusted EPS to a range of $38.05 to $38.55, up from the previous range of $37.10 to $37.90.
- The revised EPS forecast surpasses the market estimate, which was $37.62.
- The company is hosting its 2025 Investor Day today, starting at 9:30 am ET, to discuss their strategic priorities for the coming years.
- McKesson is introducing segment-specific targets within a new reporting structure.
- The company has increased its long-term growth target for Adjusted Earnings per Diluted Share to 13% to 16%, compared to the prior target of 12% to 14%.
- Analyst ratings for McKesson stand at 15 buying recommendations, 3 holds, and no sell ratings.
Mckesson Corp on Smartkarma
Analysts on Smartkarma are keen on McKesson Corp, with a bullish sentiment reflected in their research reports. Baptista Research highlighted McKesson Corporation’s strong operational and financial results in the first quarter of fiscal 2026. The company’s revenue saw a significant 23% increase year-over-year, propelled by higher prescription volumes and strategic acquisitions.
In another report, Baptista Research commended McKesson’s robust financial performance in the fourth quarter and fiscal year 2025. The company achieved a record consolidated revenue of $359 billion, showing substantial progress and surpassing long-term growth targets. With analysts like Baptista Research viewing McKesson as a growth play with promising investments and revenues, the future looks bright for the healthcare distribution giant.
A look at Mckesson Corp Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 0 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 4 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 2.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Mckesson Corp has a positive long-term outlook with strong scores in Growth, Resilience, and Momentum. A high Growth score indicates potential for the company to expand and increase its market presence over time. The Resilience score suggests that Mckesson is well-positioned to weather economic downturns or challenges. Additionally, a solid Momentum score indicates the company is showing positive performance and investor interest.
Mckesson Corporation, a major player in distributing pharmaceuticals and healthcare products, has a promising future ahead as indicated by its favorable Smartkarma Smart Scores. With a focus on growth, resilience, and momentum, Mckesson is poised to prosper in the competitive healthcare industry by catering to North American markets and offering innovative software solutions to integrate health data effectively.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
